首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1471952

不孕不育检测市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、检测试剂盒、样本、最终用户和地理位置

Infertility Testing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Test Kits, Sample, End User, and Geography

出版日期: 2024年03月04日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格

简介目录

根据我们关于「2028 年不孕症检测市场预测- COVID-19 影响和全球分析- 按类型、检测套件、样本和最终用户、地理位置」的新研究，预计市场规模将从2022 年的4.242 亿美元成长到2030年达到8.2008亿美元；预计 2022-2030 年复合年增长率为 8.6%。市场成长归因于男性和女性不孕症病例的增加以及不孕症检测的不断进步。不断加强的宣传活动可能为不孕症检测市场提供成长机会。然而，缺乏对不孕症检测试剂盒的认识和限制阻碍了高压氧治疗市场的成长。

根据 Elsevier BV 发表的一项题为「生育与不孕症：定义与流行病学」的研究，已知不孕症影响着全世界约 8-12% 的夫妇。由于现代生活方式、疾病、生育延迟等多种原因，这一比例正逐渐增加。在男性生殖系统中，不孕最常见的原因是精液射出问题、精子缺失或少量、或精子的形状（形态）和运动（活力）异常。对女性来说，不孕症可能是由子宫、卵巢、输卵管和内分泌系统异常引起的。

2022年，北美在全球不孕症检测市场中占据主要份额。该地区市场成长的推动因素包括不孕症发生率高、男性和女性对不孕症检测意识的提高、受多囊性卵巢症候群影响的女性人口不断增加、女性首次怀孕年龄的上升以及不孕不育检测试剂盒的容易取得透过电子商务网站。此外，生活方式的改变以及导致男性和女性不孕症和妇科疾病的不健康饮食趋势的增加也是不孕症检测市场成长的原因。此外，排卵监测仪的技术进步正在推动该地区的市场成长。此外，吸烟和烟草消费的增加将导致不孕症病例增加，从而推动市场成长。女性对自我测试和远端监控测试的需求不断增长以及新产品的创新预计将创造有利可图的市场机会。

不断增强的意识活动推动了不孕症检测市场的成长机会

传统上，夫妻之间的怀孕问题被归咎于女性不孕。然而，现代人类科学和深入研究已经导致社会耻辱的转变，人们开始关注男性不孕症。最近，男性正在接受测试并开始了解导致不孕症的因素。儘管世界某些地区的情况正在改善，但不同地区和地区仍然不知道新的检测和治疗方案以及病情的可用性。

这为组织和公司提供了举办和组织宣传活动的机会，以阐明全球很大一部分男性面临的这个敏感但重要的问题。例如，2020 年 11 月，Nova IVF Fertility 与《印度时报》合作发起了一场名为「生育对话」的运动，举办社交聚会，并与该领域的专家讨论男性和女性之间的不孕问题。此外，库柏外科公司(Cooper Surgical) 旗下的库柏基因公司(Cooper Genomics) 发起了全国不孕不育意识週：不孕不育揭秘活动，教育普通民众了解不孕不育的影响，并让患者了解该公司提供的产品和服务，以增强全球家庭的能力。因此，适当的宣传活动预计将为公司提供强大的展示平台，从而提供成长机会，在动态生态系统中推动收入。

基于类型的见解

根据类型，不孕症检测市场分析是透过考虑以下细分市场进行的：男性和女性。到 2022 年，女性不孕症检测领域将占据更大的市场份额。

女性生育率下降、女性妇科问题日益普遍、职业女性忙碌的生活方式导致更大的压力以及卵子数低是造成不孕症检测市场份额高的主要因素。此外，许多女性不孕症测试的可用性有助于女性不孕症测试领域的市场成长。

基于测试套件的见解

依检测试剂盒划分，不孕症检测市场分为人类卵泡刺激素（FSH）检测试剂盒、人类绒毛膜促性腺激素（HCG）检测试剂盒、黄体生成素（LH）检测试剂盒等。就收入而言，人类卵泡刺激素（FSH）检测试剂盒细分市场在2022年主导不孕症检测市场份额。

卵泡刺激素 (FSH) 检测试剂盒有助于测量血液中 FSH 荷尔蒙的浓度。此测试通常用于评估男性和女性因各种原因（例如生育问题、更年期或性发育问题）的 FSH 水平。此外，先进的 FSH 生物相似药产品、监管部门的批准、市场准入、 FSH 试剂盒生产的技术进步以及对有效避孕方案日益增长的需求预计将加速全球市场的成长。

基于最终用户的见解

依最终用户划分，不孕症检测市场分为医院和诊所、生育中心和家庭护理。家庭护理领域在 2022 年占据最大的市场份额，预计在预测期内复合年增长率最高为 9.0%。

领先企业正在实施扩张、合作、推出新产品和获取新客户群等策略，以挖掘目前的商机。

2023 年 8 月，Trajan Scientific and Medical 向 Fertilly 提供了 CE-IVD 註册的 Mitra 设备。这家德国新创公司推出了欧洲首个使用干血微量样本和 VAMS 技术的家庭生育力测试套件。

2021 年 2 月，Fertility Focus 与 ExSeed Health（从事家庭精子检测）合作，为计划怀孕的人提供解决方案。

2020 年 6 月，Modern Fertility 推出了排卵和妊娠检测试剂盒以及一款集中生育相关资料的行动应用程式。

2020 年 3 月，Proov 的家用排卵测试套件获得 FDA 批准。

美国食品药物管理局、疾病管制与预防中心 (CDC) 以及全球疾病负担研究是准备不孕症检测市场报告时参考的主要和次要来源。

欧洲
- 德国
- 法国
- 义大利
- 西班牙
- 英国
- 欧洲其他地区
亚太
- 澳洲
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区

第 12 章：产业格局

併购
协议、合作、合资企业
新产品发布
扩张和其他策略发展

第13章：竞争格局

关键参与者的热图分析
公司定位与专注

第 14 章：不孕症检测市场 - 主要公司简介

Merck KGaA
Procter & Gamble
bioMerieux SA
Alere Inc.
Babystart Ltd.
bioZhena Corporation
Quidel Corporation
SCSA Diagnostics, Inc.
CENTOGENE N.V.
Boditech Med Inc.

第 15 章：附录

简介目录

Product Code: TIPHE100001421

According to our new research study on "Infertility Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, Test Kits, Sample, and End User, Geography" the market is anticipated to grow from US$ 424.20 million in 2022 to US$ 820.08 million by 2030; it is estimated to register a CAGR of 8.6% during 2022-2030. Market growth is attributed to the increasing cases of infertility in men and women and growing advancements in infertility testing. Growing awareness campaigns will likely provide growth opportunities for the infertility testing market. However, the lack of awareness and limitations associated with infertility testing kits hinder the growth of the hyperbaric oxygen therapy market.

According to a study titled "Fertility and Infertility: Definition and Epidemiology," published in Elsevier B.V., infertility is known to affect around 8-12% of couples across the world. The proportion is gradually increasing due to several causes such as modern lifestyles, illnesses, and the postponement of parenthood. In the male reproductive system, infertility is most often caused by problems ejecting semen, missing or small amounts of sperm, or abnormal shape (morphology) and movement (motility) of sperm. In females, infertility can be caused by abnormalities associated with the uterus, ovaries, fallopian tubes, and endocrine system.

North America accounted for a major share of the global infertility testing market in 2022. The North American infertility testing market is segmented into the US, Canada, and Mexico. The market growth in this region is driven by the high occurrence of infertility, increasing awareness of infertility testing among men and women, the growing female population affected by PCOS, the rising age of first pregnancy among women, and the easy availability of infertility test kits through e-commerce websites. Also, changing lifestyles with increasing trends of unhealthy diets leading to infertility and gynecological disorders in men and women are responsible for the infertility testing market growth. Furthermore, technological advancements in ovulation monitors are bolstering the market growth in the region. Furthermore, the rising consumption of smoking and tobacco will lead to an increase in infertility cases, propelling the market growth. Growing demand for self-testing and remote monitoring testing among women and innovation of new products are expected to create profitable market opportunities.

Growing Awareness Campaigns Fuels the Infertility Testing Market Growth Opportunities

The pregnancy issues among couples have been traditionally blamed on females for being infertile. However, the modern age of human science and in-depth research and studies have led to a shift in the social stigma with a light on infertility among men. Recently, males are being tested and becoming aware of factors responsible for infertility. Although the scenario is improving in some regions of the world, various parts and geographies are still unaware of the availability of new testing and treatment options as well as the condition.

This provides organizations and companies opportunities to hold and organize awareness campaigns that shed light on this sensitive yet important issue faced by a significant percentage of males across the globe. For instance, in November 2020, Nova IVF Fertility in collaboration with the Times of India, initiated a movement called "Fertile Conversations" that hosted social meet-ups and discussions for infertility issues among males and females with experts in the field. In addition, Cooper Genomics, a Cooper Surgical company, launched the National Infertility Awareness Week: Infertility Uncovered campaign to educate the common people regarding the impact of infertility and well-aware patients regarding products and services available with the company to empower families worldwide. Thus, appropriate awareness campaigns are expected to provide robust showcasing platforms for companies, thereby offering growth opportunities to propel revenues within the dynamic ecosystem.

Type -Based Insights

Based on type, the infertility testing market analysis is carried out by considering the following segments: male and female. The female infertility testing segment held a larger market share in 2022. The male infertility testing segment is anticipated to register a higher CAGR of 9.2% during the forecast period.

Declining female fertility rates, increasing prevalence of gynecological issues in women, busier lifestyles of working women leading to more stress, and low egg counts are among the main factors responsible for the high infertility testing market share. Additionally, the availability of many female infertility tests contributes to the market growth for the female infertility testing segment.

Test Kits -Based Insights

By test kits, the infertility testing market is segmented into human follicular stimulating hormone (FSH) test kits, human chorionic gonadotropin (HCG) hormone test kits, luteinizing hormone (LH) test kits, and others. In terms of revenue, the human follicular stimulating hormone (FSH) test kits segment dominated the infertility testing market share in 2022. The highest CAGR of 9.2% is anticipated to be registered during the forecast period.

The follicular stimulating hormone (FSH) test kit helps measure the concentration of FSH hormone in the blood. The test is often used to assess FSH levels in men and women for various reasons such as fertility problems, menopause, or problems with sexual development. In addition, advanced biosimilar FSH products, regulatory approvals, market access, technological advances in FSH kit production, and a growing need for effective contraceptive options are predicted to accelerate global market growth.

End User -Based Insights

The infertility testing market, by end user, is categorized into hospitals & clinics, fertility centers, and homecare. The homecare segment held the largest market share in 2022 and is anticipated to register the highest CAGR of 9.0% during the forecast period.

Leading players are implementing strategies such as expansion, partnership, launch of new products, and acquiring a new customer base to tap prevailing business opportunities.

In August 2023, Trajan Scientific and Medical supplied CE-IVD registered Mitra devices to Fertilly. This German start-up launched Europe's first at-home fertility testing kits using dried blood micro samples with VAMS technology.

In February 2021, Fertility Focus partnered with ExSeed Health (which deals in at-home sperm testing) to provide solutions for those planning pregnancy.

In June 2020, Modern Fertility launched ovulation and pregnancy test kits and a mobile application to centralize fertility-related data.

In March 2020, Proov received FDA approval for its home ovulation test kit.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are the primary and secondary sources referred to while preparing the infertility testing market report.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Infertility Testing Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Infertility Testing Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Infertility Testing Market - Global Market Analysis

6.1 Infertility Testing - Global Market Overview
6.2 Infertility Testing - Global Market and Forecast to 2031

7. Infertility Testing Market - Revenue Analysis (USD Million) - By Type, 2021-2031

7.1 Overview
7.2 Female Infertility Testing
7.3 Male Infertility Testing

8. Infertility Testing Market - Revenue Analysis (USD Million) - By Test Kits, 2021-2031

8.1 Overview
8.2 Human Follicular Stimulating Hormone (FSH) Urine Test Kits
8.3 Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits
8.4 Luteinizing Hormone (LH) Test Kits
8.5 Others

9. Infertility Testing Market - Revenue Analysis (USD Million) - By Sample, 2021-2031

9.1 Overview
9.2 Blood
9.3 Urine
9.4 Others

10. Infertility Testing Market - Revenue Analysis (USD Million) - By End User, 2021-2031

10.1 Overview
10.2 Hospitals & Clinics
10.3 Fertility Centers
10.4 Homecare

11. Infertility Testing Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

11.1 North America
- 11.1.1 North America Infertility Testing Market Overview
- 11.1.2 North America Infertility Testing Market Revenue and Forecasts to 2031
- 11.1.3 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Type
- 11.1.4 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Test Kits
- 11.1.5 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Sample
- 11.1.6 North America Infertility Testing Market Revenue and Forecasts and Analysis - By End User
- 11.1.7 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Countries
  - 11.1.7.1 United States Infertility Testing Market
    - 11.1.7.1.1 United States Infertility Testing Market, by Type
    - 11.1.7.1.2 United States Infertility Testing Market, by Test Kits
    - 11.1.7.1.3 United States Infertility Testing Market, by Sample
    - 11.1.7.1.4 United States Infertility Testing Market, by End User
  - 11.1.7.2 Canada Infertility Testing Market
    - 11.1.7.2.1 Canada Infertility Testing Market, by Type
    - 11.1.7.2.2 Canada Infertility Testing Market, by Test Kits
    - 11.1.7.2.3 Canada Infertility Testing Market, by Sample
    - 11.1.7.2.4 Canada Infertility Testing Market, by End User
  - 11.1.7.3 Mexico Infertility Testing Market
    - 11.1.7.3.1 Mexico Infertility Testing Market, by Type
    - 11.1.7.3.2 Mexico Infertility Testing Market, by Test Kits
    - 11.1.7.3.3 Mexico Infertility Testing Market, by Sample
    - 11.1.7.3.4 Mexico Infertility Testing Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

11.2 Europe
- 11.2.1 Germany
- 11.2.2 France
- 11.2.3 Italy
- 11.2.4 Spain
- 11.2.5 United Kingdom
- 11.2.6 Rest of Europe
11.3 Asia-Pacific
- 11.3.1 Australia
- 11.3.2 China
- 11.3.3 India
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 Rest of Asia-Pacific
11.4 Middle East & Africa
- 11.4.1 South Africa
- 11.4.2 Saudi Arabia
- 11.4.3 U.A.E
- 11.4.4 Rest of Middle East & Africa
11.5 South & Central America
- 11.5.1 Brazil
- 11.5.2 Argentina
- 11.5.3 Rest of South & Central America

12. Industry Landscape

12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration

14. Infertility Testing Market - Key Company Profiles

14.1 Merck KGaA
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies